Navigation Links
China Biologic Products to Present at Brean Murray, Carret 2010 China Growth Conference
Date:11/15/2010

China Biologic Products to Present at Brean Murray, Carret 2010 China Growth... -- TAI'AN, China, Nov. 15, 2010 /PRNewswire-Asia-FirstCall/ --


Advanced Search Search

  
Close
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Biotechnology, Health Care & Hospitals, Medical Pharmaceuticals, Trade Show News Click to view news release full screen  

China Biologic Products to Present at Brean Murray, Carret 2010 China Growth Conference

 

TAI'AN, China, Nov. 15, 2010 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (Nasdaq: CBPO) ("China Biologic," or the "Company"), a leading plasma-based biopharmaceutical company in China, today announced that the Company's management will present at the upcoming Brean Murray, Carret & Co. 2010 China Growth Conference. Date:

November 17, 2010 Time:

09:20 a.m. ESTPresenter:

Ming Yin, Vice President - Finance Location:

Track IIThe Millennium Broadway Hotel145 West 44th StreetNew York, New York 10036The Brean Murray, Carret & Co. 2010 China Growth Conference is a two-day conference (November 17-18, 2010) that consists of 25-minute presentation slots followed by 10-minutes of open floor Q&A sessions with institutional investors. Senior management of presenting companies, industry experts, and institutional investors will receive a unique and comprehensive view of China from a global perspective. China Biologic's management will be available for 1x1 meetings before and after the Company's presentation.

About China Biologic Products, Inc.China Biologic Products, Inc. (the "Company"), through its indirect majority-owned subsidiaries, Shandong Taibang Biological Products Co., Ltd. and Guiyang Dalin Biological Technologies Co., Ltd, and its equity investment in Xi'an Huitian Blood Products Co., Ltd., is currently one of the leading plasma-based biopharmaceutical company in China. The Company is a fully integrated biological products company with plasma collection, production and manufacturing, research and development and commercial operations. The Company's plasma-based biopharmaceutical products are irreplaceable during medical emergencies, and are used for the prevention and treatment of various diseases. The Company sells its products to hospitals and other healthcare facilities in China.

Company Contact:Mr. Ming YinVice President - FinanceChina Biologic Products, Inc.Tel: +86-851-3605846Email: IR@chinabiologic.comwww.chinabiologic.com Investor Relations Contact:Mr. Crocker Coulson, President CCG Investor RelationsPhone: +1 (646) 213-1915Email: crocker.coulson@ccgir.comwww.ccgirasia.com
'/>"/>

SOURCE China Biologic Products, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. China-Biotics Appoints New Chief Operating Officer
2. China Biologic Products Schedules Conference Call to Discuss Third Quarter 2010 Results
3. China-Biotics to Report Fiscal Year 2011 Second Quarter Financial Results on November 9
4. Verenium Announces Regulatory Approval for Purifine® PLC in China
5. China Cord Blood Corporation Files Its Annual Report on Form 20-F/A
6. Reportlinker Adds Industrial Biotechnology China News 1009
7. According to Opurity, Feds Put U.S. Consumers at Risk: PTO Bureaucrats Refuse to Approve Vitamin Companys China-Free Trademark
8. Biopharma Leaders to Reveal Successful Strategies for China, India at the PharmAsia Summit in San Francisco
9. China Cord Blood Corporation Updates Status Regarding Share Repurchase Program
10. China Pharma Holdings, Inc. Successfully Completes Phase I Clinical Trials of New Anti-Drug-Resistance Antibiotic
11. China-Biotics Hosted its First Investor Day Event
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/15/2017)... ... August 15, 2017 , ... Coffea arabica accounts for ... abiotic factors. During this educational webinar, participants will learn about the importance of ... a better understanding of how genomics is important for coffee breeding improvement. , ...
(Date:8/11/2017)... 2017  Market researcher Kalorama Information was ... regarding the telemedicine market.  The telemedicine market ...  The article, "Heart and Asthma Monitors? ... information from Kalorama Information,s Remote Patient Monitoring ...  (Sleep, Diabetes, Vital Signs /EKG and ...
(Date:8/10/2017)... Philadelphia, PA (PRWEB) , ... August 09, 2017 ... ... back to the classroom next week-- as students. From August 14th through the ... Institute. The institute, which debuted in the summer of 2016, provides Philadelphia-based middle ...
(Date:8/10/2017)... and London UK (PRWEB) , ... August 10, 2017 , ... ... will host a new educational webinar to demonstrate how Good Clinical Practice ... contracts, and site documents. In addition the webinar will discuss the importance of GCP ...
Breaking Biology Technology:
(Date:4/13/2017)... According to a new market research report "Consumer ... Administration, and Authorization), Service, Authentication Type, Deployment Mode, Vertical, and Region - ... to grow from USD 14.30 Billion in 2017 to USD 31.75 Billion ... ... MarketsandMarkets Logo ...
(Date:4/11/2017)... 11, 2017 NXT-ID, Inc. (NASDAQ:   ... announces the appointment of independent Directors Mr. Robin D. ... Board of Directors, furthering the company,s corporate governance and expertise. ... Gino Pereira , ... forward to their guidance and benefiting from their considerable expertise ...
(Date:4/5/2017)... 2017 KEY FINDINGS The global ... a CAGR of 25.76% during the forecast period of ... factor for the growth of the stem cell market. ... MARKET INSIGHTS The global stem cell market is ... geography. The stem cell market of the product is ...
Breaking Biology News(10 mins):